Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antibiotics"" wg kryterium: Temat


Starter badań:

Tytuł:
Evaluating diagnostic performance of Truenat MTB Plus for gastrointestinal tuberculosis.
Autorzy:
Sharma K; Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma M; Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Department of Microbiology, All India Institute of Medical Sciences, Bilaspur, India.
Sharma V; Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma M; Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Samanta J; Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma A; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kochhar R; Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sinha SK; Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2022 Aug; Vol. 37 (8), pp. 1571-1578. Date of Electronic Publication: 2022 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Antibiotics, Antitubercular*
Mycobacterium tuberculosis*/genetics
Tuberculosis, Gastrointestinal*/diagnosis
Tuberculosis, Pulmonary*
Drug Resistance, Bacterial ; Humans ; Rifampin/pharmacology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis.
Autorzy:
Aggarwal AN; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Agarwal R; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Dhooria S; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Prasad KT; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sehgal IS; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Muthu V; Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 11; Vol. 17 (7), pp. e0268483. Date of Electronic Publication: 2022 Jul 11 (Print Publication: 2022).
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*/genetics
Pleural Effusion*/diagnosis
Pleural Effusion*/microbiology
Tuberculosis*/drug therapy
Humans ; Rifampin ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste.
Autorzy:
Lopes C; National TB Programme, Ministry of Health, Dili, Timor-Leste.
Kundu D; World Health Organization Country Office for Timor-Leste, Dili, Timor-Leste. .
Da Costa Barreto I; National Health Laboratory, Ministry of Health, Dili, Timor-Leste.
da Cruz B; National HIV Programme, Ministry of Health, Dili, Timor-Leste.
Siva Kumar S; National Institute for Research in Tuberculosis, Chennai, India.
Ramalingam S; National Health Laboratory, Ministry of Health, Dili, Timor-Leste.; National TB Reference Laboratory, Dili, Timor-Leste.
Dean AS; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Bhatia V; World Health Organization South East Asia Regional Office, New Delhi, India.
Seenivasan P; National Institute for Research in Tuberculosis, Chennai, India.
Padmapriyadarsini C; National Institute for Research in Tuberculosis, Chennai, India.
Auguet OT; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Pokaż więcej
Źródło:
Global health research and policy [Glob Health Res Policy] 2022 May 20; Vol. 7 (1), pp. 16. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*/genetics
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/epidemiology
Cross-Sectional Studies ; Drug Resistance, Bacterial ; Humans ; India/epidemiology ; Microbial Sensitivity Tests ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Sensitivity and Specificity ; Timor-Leste/epidemiology
Czasopismo naukowe
Tytuł:
Characterization of probes associated with rifampicin resistance in M.tuberculosis detected by GenXpert from a national reference laboratory at Chennai.
Autorzy:
Rajendran P; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Kumar MP; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Thiruvengadam K; Department of Epidemiology, ICMR - National Institute for Research in Tuberculosis, India.
Sreenivasan P; National Tuberculosis Elimination Programme Consultant, ICMR -National Institute for Research in Tuberculosis, India.
Veeraraghavan T; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Ramalingam R; National Tuberculosis Elimination Programme Consultant, ICMR -National Institute for Research in Tuberculosis, India.
Hasini S; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Dhanaraju T; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Kuppamuthu R; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Shanmugam S; Department of Bacteriology, ICMR - National Institute for Research in Tuberculosis, India.
Frederick A; National Tuberculosis Elimination Programme, State TB Cell, India.
Padmapriyadarsini C; ICMR -National Institute for Research in Tuberculosis, India. Electronic address: .
Pokaż więcej
Źródło:
Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2022 Mar; Vol. 133, pp. 102182. Date of Electronic Publication: 2022 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*/genetics
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis, Multidrug-Resistant*/diagnosis
Tuberculosis, Multidrug-Resistant*/drug therapy
Drug Resistance, Bacterial/genetics ; Humans ; India ; Retrospective Studies ; Rifampin/pharmacology ; Rifampin/therapeutic use
Czasopismo naukowe
Tytuł:
Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis.
Autorzy:
Yu W; Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, Zhejiang, China.
Shen Y; Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, Zhejiang, China.
Zhu P; Zhejiang Tuberculosis Diagnosis and Treatment Center, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, Zhejiang, China.
Chen D; Department of Thoracic Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2022 May 20; Vol. 101 (20), pp. e29363. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*/genetics
Tuberculosis, Pleural*/diagnosis
Tuberculosis, Pleural*/drug therapy
Tuberculosis, Pulmonary*/drug therapy
Humans ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus: Mixed-Methods Study.
Autorzy:
Sereda Y; World Health Organization Regional Office for Europe, Marmorvej 51, DK-2100 Copenhagen, Denmark.
Korotych O; World Health Organization Regional Office for Europe, Marmorvej 51, DK-2100 Copenhagen, Denmark.
Klimuk D; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, 157 Dolginovskij trakt, 220053 Minsk, Belarus.
Zhurkin D; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, 157 Dolginovskij trakt, 220053 Minsk, Belarus.
Solodovnikova V; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, 157 Dolginovskij trakt, 220053 Minsk, Belarus.
Grzemska M; World Health Organization Regional Office for Europe, Marmorvej 51, DK-2100 Copenhagen, Denmark.
Grankov V; World Health Organization Country Office in Belarus, Fabriciusa str. 28 (Room 401), 220007 Minsk, Belarus.
Hurevich H; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, 157 Dolginovskij trakt, 220053 Minsk, Belarus.
Yedilbayev A; World Health Organization Regional Office for Europe, Marmorvej 51, DK-2100 Copenhagen, Denmark.
Skrahina A; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, 157 Dolginovskij trakt, 220053 Minsk, Belarus.
Pokaż więcej
Źródło:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Apr 05; Vol. 19 (7). Date of Electronic Publication: 2022 Apr 05.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antibiotics, Antitubercular*/therapeutic use
COVID-19*/epidemiology
Coinfection*/drug therapy
Coinfection*/epidemiology
Latent Tuberculosis*/drug therapy
Mycobacterium tuberculosis*
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis*/epidemiology
Adult ; COVID-19 Testing ; Hospitalization ; Humans ; Male ; Middle Aged ; Pandemics ; Republic of Belarus/epidemiology ; Rifampin ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81.
Autorzy:
Golani LK; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Divović B; Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
Sharmin D; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Pandey KP; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Mian MY; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Cerne R; Laboratory of Antiepileptic Drug Discovery, Ascencion St. Vincent, Indianapolis, Indiana, USA.; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, Indiana, USA.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; RespireRx Pharmaceuticals Inc, Glen Rock, New Jersey, USA.
Zahn NM; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Meyer MJ; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Tiruveedhula VVNPB; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Smith JL; Laboratory of Antiepileptic Drug Discovery, Ascencion St. Vincent, Indianapolis, Indiana, USA.
Ping X; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, Indiana, USA.
Jin X; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, Indiana, USA.
Lippa A; RespireRx Pharmaceuticals Inc, Glen Rock, New Jersey, USA.
Schkeryantz JM; Bristol Myers Squibb, Cambridge, Massachusetts, USA.
Arnold LA; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Cook JM; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.; RespireRx Pharmaceuticals Inc, Glen Rock, New Jersey, USA.
Savić MM; Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
Witkin JM; Department of Chemistry & Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.; Laboratory of Antiepileptic Drug Discovery, Ascencion St. Vincent, Indianapolis, Indiana, USA.; RespireRx Pharmaceuticals Inc, Glen Rock, New Jersey, USA.
Pokaż więcej
Źródło:
Biopharmaceutics & drug disposition [Biopharm Drug Dispos] 2022 Apr; Vol. 43 (2), pp. 66-75. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Antibiotics, Antitubercular*
Anticonvulsants*/pharmacology
Animals ; Oxazoles/metabolism ; Rats ; Receptors, GABA-A/metabolism
Czasopismo naukowe
Tytuł:
Sdox, a H 2 S releasing anthracycline, with a safer profile than doxorubicin toward vasculature.
Autorzy:
Durante M; Dipartimento di Scienze della Vita, Università di Siena, Siena, Italy.
Frosini M; Dipartimento di Scienze della Vita, Università di Siena, Siena, Italy.
Chiaino E; Dipartimento di Scienze della Vita, Università di Siena, Siena, Italy.
Fusi F; Dipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, Siena, Italy.
Gamberucci A; Dipartimento di Medicina Molecolare e dello Sviluppo, Università di Siena, Siena, Italy.
Gorelli B; Dipartimento di Scienze della Vita, Università di Siena, Siena, Italy.
Chegaev K; Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Torino, Italy.
Riganti C; Dipartimento di Oncologia, Università di Torino, Torino, Italy.
Saponara S; Dipartimento di Scienze della Vita, Università di Siena, Siena, Italy. Electronic address: .
Pokaż więcej
Źródło:
Vascular pharmacology [Vascul Pharmacol] 2022 Apr; Vol. 143, pp. 106969. Date of Electronic Publication: 2022 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Anthracyclines*/metabolism
Anthracyclines*/pharmacology
Antibiotics, Antineoplastic*/pharmacology
Doxorubicin/pharmacology ; Muscle, Smooth, Vascular ; Myocytes, Smooth Muscle/metabolism
Czasopismo naukowe
Tytuł:
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.
Autorzy:
Dhana A; Department of Medicine, University of Cape Town, Cape Town, South Africa.
Hamada Y; Centre for International Cooperation and Global Tuberculosis Information, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan; Institute for Global Health, University College London, London, UK.
Kengne AP; Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.
Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, CA, USA.
Rangaka MX; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Institute for Global Health, University College London, London, UK.
Kredo T; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Baddeley A; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Miller C; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Singh S; Global HIV, Hepatitis and STIs Programme, World Health Organization, Geneva, Switzerland.
Hanifa Y; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Fielding K; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Affolabi D; Laboratoire de Référence des Mycobactéries, Cotonou, Benin.
Merle CS; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland.
Wachinou AP; National Hospital for Tuberculosis and Pulmonary Diseases, Cotonou, Benin.
Yoon C; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University of California, San Francisco, CA, USA.
Cattamanchi A; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University of California, San Francisco, CA, USA.
Hoffmann CJ; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Martinson N; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, USA.
Mbu ET; Bamenda Regional Hospital HIV Treatment Center, Bamenda, Cameroon.
Sander MS; Tuberculosis Reference Laboratory Bamenda, Bamenda, Cameroon.
Balcha TT; Clinical Infection Medicine, Lund University, Malmö, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden.
Skogmar S; Department of Translational Medicine, Lund University, Malmö, Sweden.
Reeve BWP; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Theron G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Ndlangalavu G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Modi S; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cavanaugh J; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Swindells S; University of Nebraska Medical Center, Omaha, NE, USA.
Chaisson RE; Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, USA.
Ahmad Khan F; McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Howard AA; ICAP at Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Wood R; Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Thit SS; Department of Medicine, University of Medicine 2, Yangon, Yangon Division, Myanmar.
Kyi MM; Department of Medicine, University of Medicine 2, Yangon, Yangon Division, Myanmar.
Hanson J; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Drain PK; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Shapiro AE; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
Kufa T; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
Churchyard G; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; The Aurum Institute, Parktown, South Africa.
Nguyen DT; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Graviss EA; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Bjerrum S; Department of Clinical Research, Infectious Diseases, University of Southern Denmark, Odense, Denmark.
Johansen IS; Research Unit for Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
Gersh JK; University of Washington, Seattle, WA, USA.
Horne DJ; Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA, USA.
LaCourse SM; Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Global Health, Division of Infectious Diseases, University of Washington, Seattle, WA, USA.
Al-Darraji HAA; Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.
Kamarulzaman A; Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.
Kempker RR; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Tukvadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Barr DA; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Meintjes G; Department of Medicine, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Maartens G; Department of Medicine, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: .
Pokaż więcej
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Apr; Vol. 22 (4), pp. 507-518. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibiotics, Antitubercular*/therapeutic use
HIV Infections*/complications
HIV Infections*/drug therapy
Mycobacterium tuberculosis*
Tuberculosis*/diagnosis
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Adolescent ; Adult ; Child ; Cross-Sectional Studies ; Humans ; Prospective Studies ; Rifampin ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns.
Autorzy:
Donkeng-Donfack VF; Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon. .
Tchatchueng-Mbougua JB; Epidemiology and Public Health Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Abanda NN; Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon.
Ongboulal SM; Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon.
Djieugoue YJ; Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon.
Kamdem Simo Y; Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon.
Mekemnang Tchoupa M; National Tuberculosis Control Program, Yaoundé, Cameroon.
Bekang Angui F; National Tuberculosis Control Program, Yaoundé, Cameroon.
Kuate Kuate A; National Tuberculosis Control Program, Yaoundé, Cameroon.
Mbassa V; National Tuberculosis Control Program, Yaoundé, Cameroon.
Mvondo Abeng Belinga E; National Tuberculosis Control Program, Yaoundé, Cameroon.
Eyangoh S; Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2022 Mar 04; Vol. 22 (1), pp. 219. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Antibiotics, Antitubercular*
Mycobacterium tuberculosis*
Tuberculosis*/diagnosis
Algorithms ; Cost-Benefit Analysis ; Humans ; Mass Screening ; Rifampin/pharmacology ; Sensitivity and Specificity ; Sputum
Czasopismo naukowe
Tytuł:
Influence of lipophilicity of anthracyclines on the interactions with cholesterol in the model cell membranes - Langmuir monolayer and SEIRAS studies.
Autorzy:
Zaborowska M; Faculty of Chemistry, University of Warsaw, Pasteura 1, 02093 Warsaw, Poland.
Dziubak D; Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Żwirki i Wigury 101, 02089 Warsaw, Poland.
Fontaine P; Synchrotron Soleil, L'Orme des Merisiers, Saint Aubin, BP 48, 91192 Gif-sur-Yvette Cedex, France.
Matyszewska D; Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Żwirki i Wigury 101, 02089 Warsaw, Poland.
Pokaż więcej
Źródło:
Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2022 Mar; Vol. 211, pp. 112297. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji:
Journal Article
MeSH Terms:
Anthracyclines*
Antibiotics, Antineoplastic*/metabolism
Cell Membrane/metabolism ; Cholesterol ; Daunorubicin/metabolism
Czasopismo naukowe
Tytuł:
Dual-responsive drug release and fluorescence imaging based on disulfide-pillar[4]arene aggregate in cancer cells.
Autorzy:
Tang M; College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, PR China.
Liu YH; College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, PR China.
Xu XM; College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, PR China.
Zhang YM; College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, PR China. Electronic address: .
Liu Y; College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, PR China. Electronic address: .
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2022 Mar 01; Vol. 57, pp. 116649. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Optical Imaging*
Antibiotics, Antineoplastic/*pharmacology
Calixarenes/*pharmacology
Disulfides/*pharmacology
Doxorubicin/*pharmacology
Antibiotics, Antineoplastic/chemistry ; Calixarenes/chemistry ; Cell Line ; Cell Proliferation/drug effects ; Disulfides/chemistry ; Dose-Response Relationship, Drug ; Doxorubicin/chemistry ; Drug Liberation ; Drug Screening Assays, Antitumor ; Humans ; Molecular Structure ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial.
Autorzy:
Kritski A; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, Brasil.
Oliveira MM; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, Brasil.
Almeida IN; Universidade Federal de Ouro Preto, Escola de Farmácia, Departamento de Análises Clínicas, Ouro Preto, MG, Brasil.
Ramalho D; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, Brasil.
Andrade MKN; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, Brasil.; Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ, Brasil.
Carvalho M; Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ, Brasil.
Miranda PFC; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Programa Acadêmico de Tuberculose, Rio de Janeiro, RJ, Brasil.
Dalcolmo MP; Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Rio de Janeiro, RJ, Brasil.
Braga JU; Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Brígido T; Secretaria da Saúde do Ceará, Hospital de Messejana, Fortaleza, CE, Brasil.
Mesquita E; Secretaria de Estado de Saúde do Rio de Janeiro, Instituto Ary Parreiras, Rio de Janeiro, RJ, Brasil.
Dias C; Secretaria de Estado de Saúde do Rio Grande do Sul, Hospital Sanatório Partenon, Porto Alegre, RS, Brasil.
Gambirasio A; Secretaria de Estado da Saúde de São Paulo, Instituto Clemente Ferreira, São Paulo, SP, Brasil.
Souza Filho JB; Universidade Federal do Rio de Janeiro, Programa de Engenharia Elétrica, Departamento de Engenharia Eletrônica e de Computação, Rio de Janeiro, RJ, Brasil.
Detjen A; United Nations Children's Fund (UNICEF), New York, USA.
Phillips PPJ; Institute of Clinical Trials and Methodology, MRC Clinical Trials Unit, London, United Kingdom.; University of California, San Francisco, USA.
Langley I; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Fujiwara P; University of California, San Francisco, USA.
Squire SB; Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Pokaż więcej
Źródło:
Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2022 Feb 25; Vol. 55, pp. e0191. Date of Electronic Publication: 2022 Feb 25 (Print Publication: 2022).
Typ publikacji:
Journal Article; Pragmatic Clinical Trial
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*/genetics
Tuberculosis, Multidrug-Resistant*/diagnosis
Tuberculosis, Multidrug-Resistant*/drug therapy
Brazil ; Humans ; Microbial Sensitivity Tests ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Pooled testing of sputum with Xpert MTB/RIF and Xpert Ultra during tuberculosis active case finding campaigns in Lao People's Democratic Republic.
Autorzy:
Iem V; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.; National Tuberculosis Control Center, XJ7F+P5F, Vientiane, Lao People's Democratic Republic.
Chittamany P; National Tuberculosis Control Center, XJ7F+P5F, Vientiane, Lao People's Democratic Republic.
Suthepmany S; National Tuberculosis Control Center, XJ7F+P5F, Vientiane, Lao People's Democratic Republic.
Siphanthong S; National Tuberculosis Control Center, XJ7F+P5F, Vientiane, Lao People's Democratic Republic.
Siphanthong P; National Tuberculosis Control Center, XJ7F+P5F, Vientiane, Lao People's Democratic Republic.
Somphavong S; Center of Infectology Lao Christophe Merieux, Vientiane, Lao People's Democratic Republic.
Kontogianni K; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Dodd J; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Khan JA; Health Economics and Policy Unit, School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
Dominguez J; Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias, and Universitat Autònoma de Barcelona, Barcelona, Spain.
Wingfield T; Department of International Public Health and Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.; Department of Global Public Health, WHO Collaborating Centre for Tuberculosis and Social Medicine, Karolinska Institutet, Stockholm, Sweden.
Creswell J; Stop TB Partnership, Geneva, Switzerland.
Cuevas LE; Clinical Sciences and Recsearch Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK .
Pokaż więcej
Źródło:
BMJ global health [BMJ Glob Health] 2022 Feb; Vol. 7 (2).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/epidemiology
Drug Resistance, Bacterial ; Humans ; Laos ; Rifampin ; Sensitivity and Specificity ; Sputum/microbiology
Czasopismo naukowe
Tytuł:
Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin.
Autorzy:
Mvelase NR; Department of Medical Microbiology, KwaZulu-Natal Academic Complex, National Health Laboratory Service, Level 4, Pathology Laboratory Building, Inkosi Albert Luthuli Central Hospital, Durban 4091, South Africa; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa. Electronic address: .
Mlisana KP; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; Academic Affairs, Research and Quality Assurance, National Health Laboratory Service, Johannesburg, South Africa.
Pokaż więcej
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Feb; Vol. 22 (2), pp. 156-157. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Tuberculosis, Multidrug-Resistant*/diagnosis
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Rifampin/pharmacology ; Rifampin/therapeutic use
Czasopismo naukowe
Tytuł:
Mitochondrial Dysfunction and Antioxidation Dyshomeostasis-Enhanced Tumor Starvation Synergistic Chemotherapy Achieved using a Metal-Organic Framework-Based Nano-Enzyme Reactor.
Autorzy:
Huo T; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
Leilei Chen; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
Nie H; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
Li W; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
Lin C; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
Akhtar M; Department of Pharmaceutics, Faculty of Pharmacy, and Department of Medical Laboratory Technology, Faculty of Medicine and Allied Health Sciences, The Islamia University of Bahawalpur, Bahawalpur 63100, Punjab, Pakistan.
Huang R; Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2022 Jan 26; Vol. 14 (3), pp. 3675-3684. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Antibiotics, Antineoplastic/*pharmacology
Antioxidants/*pharmacology
Biocompatible Materials/*pharmacology
Doxorubicin/*pharmacology
Metal-Organic Frameworks/*pharmacology
Neoplasms/*drug therapy
Antibiotics, Antineoplastic/chemistry ; Antibiotics, Antineoplastic/metabolism ; Antioxidants/chemistry ; Antioxidants/metabolism ; Biocompatible Materials/chemistry ; Biocompatible Materials/metabolism ; Doxorubicin/chemistry ; Doxorubicin/metabolism ; Glucose Oxidase/metabolism ; Homeostasis/drug effects ; Humans ; Imidazoles/chemistry ; Imidazoles/metabolism ; Imidazoles/pharmacology ; Materials Testing ; Metal-Organic Frameworks/chemistry ; Metal-Organic Frameworks/metabolism ; Mitochondrial Dynamics/drug effects ; Neoplasms/metabolism ; Zeolites/chemistry ; Zeolites/metabolism ; Zeolites/pharmacology
Czasopismo naukowe
Tytuł:
Chitosan-based DDSs for pH/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity.
Autorzy:
Xie P; State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
Liu P; State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Electronic address: .
Pokaż więcej
Źródło:
Carbohydrate polymers [Carbohydr Polym] 2022 Jan 01; Vol. 275, pp. 118760. Date of Electronic Publication: 2021 Oct 16.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Delivery Systems*
Antibiotics, Antineoplastic/*pharmacology
Cell Hypoxia/*drug effects
Chitosan/*chemistry
Doxorubicin/*pharmacology
Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/chemistry ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Chitosan/administration & dosage ; Doxorubicin/administration & dosage ; Doxorubicin/chemistry ; Drug Carriers/administration & dosage ; Drug Carriers/chemistry ; Drug Liberation ; Drug Screening Assays, Antitumor ; Flow Cytometry ; Hep G2 Cells ; Humans ; Hydrogen-Ion Concentration ; Molecular Structure ; Nanoparticles/chemistry ; Particle Size
Czasopismo naukowe
Tytuł:
Diagnostic accuracy of Xpert ultra for childhood tuberculosis: A preliminary systematic review and meta-analysis.
Autorzy:
Signorino C; Post-graduate School of Pediatrics, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
Votto M; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
De Filippo M; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Marseglia GL; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Galli L; Division of Pediatric Infectious Disease, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
Chiappini E; Division of Pediatric Infectious Disease, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
Pokaż więcej
Źródło:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2022 Jan; Vol. 33 Suppl 27, pp. 80-82.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Antibiotics, Antitubercular*/pharmacology
Antibiotics, Antitubercular*/therapeutic use
Mycobacterium tuberculosis*/genetics
Tuberculosis*/diagnosis
Child ; Drug Resistance, Bacterial ; Humans ; Rifampin/pharmacology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
In Situ Nanotransformable Hydrogel for Chemo-Photothermal Therapy of Localized Tumors and Targeted Therapy of Highly Metastatic Tumors.
Autorzy:
Baseeruddin Alvi S; Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad, Telangana 502285, India.
P S R; Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad, Telangana 502285, India.
Begum N; Department of Pharmacology, G. Pulla Reddy College of Pharmacy, Hyderabad, Telangana 500028, India.
Jogdand AB; Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad, Telangana 502285, India.
Veeresh B; Department of Pharmacology, G. Pulla Reddy College of Pharmacy, Hyderabad, Telangana 500028, India.
Rengan AK; Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad, Telangana 502285, India.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Dec 01; Vol. 13 (47), pp. 55862-55878. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Photothermal Therapy*
Antibiotics, Antineoplastic/*pharmacology
Biocompatible Materials/*chemistry
Doxorubicin/*pharmacology
Hydrogels/*chemistry
Lung Neoplasms/*drug therapy
Melanoma, Experimental/*drug therapy
Nanoparticles/*chemistry
Animals ; Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/chemistry ; Biocompatible Materials/administration & dosage ; Cell Line ; Doxorubicin/administration & dosage ; Doxorubicin/chemistry ; Female ; Gold/administration & dosage ; Gold/chemistry ; Hydrogels/administration & dosage ; Injections, Subcutaneous ; Liposomes/administration & dosage ; Liposomes/chemistry ; Lung Neoplasms/pathology ; Lung Neoplasms/secondary ; Melanoma, Experimental/pathology ; Melanoma, Experimental/secondary ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Nanoparticles/administration & dosage ; Neoplasms, Experimental/drug therapy ; Neoplasms, Experimental/pathology ; Particle Size ; Surface Properties
Czasopismo naukowe
Tytuł:
pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
Autorzy:
Lages EB; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil; PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France.
Fernandes RS; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Andrade MMS; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Paiyabhroma N; PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France.
de Oliveira RB; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Fernandes C; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Cassali GD; Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Sicard P; PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France; IPAM, BioCampus Montpellier, INSERM, CNRS, Université de Montpellier, Montpellier, France.
Richard S; PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France; IPAM, BioCampus Montpellier, INSERM, CNRS, Université de Montpellier, Montpellier, France.
Branco de Barros AL; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Ferreira LAM; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Dec; Vol. 144, pp. 112373. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Prodrugs*
Antibiotics, Antineoplastic/*pharmacokinetics
Docosahexaenoic Acids/*chemistry
Doxorubicin/*pharmacokinetics
alpha-Tocopherol/*chemistry
Animals ; Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/adverse effects ; Breast Neoplasms/drug therapy ; Cell Line, Tumor ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Drug Carriers ; Drug Compounding ; Drug Liberation ; Humans ; Hydrazones/chemistry ; Hydrogen-Ion Concentration ; Lipids/chemistry ; Long QT Syndrome/chemically induced ; Mice ; Mice, Inbred BALB C ; Nanostructures ; Neoplasm Transplantation ; Ventricular Function, Left/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz